Bryan F. Cox

CIK: 0001981787

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)6 (60.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)4 (40.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

TLSI

TriSalus Life Sciences, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (10 total)

TLSI
TriSalus Life Sciences, Inc.
Oct 5, 2026
Sale(S)
Direct
296 shares at avg. $4.39$1K
TLSI
TriSalus Life Sciences, Inc.
Mar 16, 2026
Sale(S)
Direct
579 shares at avg. $4.12$2K
TLSI
TriSalus Life Sciences, Inc.
Mar 12, 2026
Sale(S)
Direct
1.5K shares at avg. $4.09$6K
TLSI
TriSalus Life Sciences, Inc.
Mar 11, 2026
Sale(S)
Direct
1.1K shares at avg. $4.13$5K
TLSI
TriSalus Life Sciences, Inc.
Nov 24, 2025
Award(A)
Direct
40K shares-
TLSI
TriSalus Life Sciences, Inc.
May 19, 2025
Sale(S)
Direct
4.8K shares at avg. $5.18$25K
TLSI
TriSalus Life Sciences, Inc.
May 19, 2025
Award(A)
Direct
15.7K shares at avg. $5.18$81K
TLSI
TriSalus Life Sciences, Inc.
Feb 18, 2025
Award(A)
Direct
11.5K shares-
TLSI
TriSalus Life Sciences, Inc.
Jan 27, 2025
Award(A)
Direct
10.6K shares-
TLSI
TriSalus Life Sciences, Inc.
Oct 5, 2024
Sale(S)
Direct
314 shares at avg. $4.44$1K

		Type	Shares	Price		Ownership
Oct 5, 2026	TLSI TriSalus Life Sciences, Inc.	Sale(S)	296	$4.39	$1,299	Direct
Mar 16, 2026	TLSI TriSalus Life Sciences, Inc.	Sale(S)	579	$4.12	$2,385	Direct
Mar 12, 2026	TLSI TriSalus Life Sciences, Inc.	Sale(S)	1,467	$4.09	$6,000	Direct
Mar 11, 2026	TLSI TriSalus Life Sciences, Inc.	Sale(S)	1,138	$4.13	$4,700	Direct
Nov 24, 2025	TLSI TriSalus Life Sciences, Inc.	Award(A)	40,000	-	-	Direct
May 19, 2025	TLSI TriSalus Life Sciences, Inc.	Sale(S)	4,764	$5.18	$24,678	Direct
May 19, 2025	TLSI TriSalus Life Sciences, Inc.	Award(A)	15,722	$5.18	$81,440	Direct
Feb 18, 2025	TLSI TriSalus Life Sciences, Inc.	Award(A)	11,450	-	-	Direct
Jan 27, 2025	TLSI TriSalus Life Sciences, Inc.	Award(A)	10,625	-	$0	Direct
Oct 5, 2024	TLSI TriSalus Life Sciences, Inc.	Sale(S)	314	$4.44	$1,394	Direct

1-10 of 10 transactions

About Cox Bryan F.

Cox Bryan F. (SEC CIK 0001981787) files insider reports with the SEC as Chief of Research of TriSalus Life Sciences, Inc. (TLSI).

Signal8 holds 7 ownership filings by Cox Bryan F., all Form 4s, filed between Dec 19, 2024 and Oct 7, 2026. Those filings report 10 transactions, from Oct 5, 2024 to Oct 5, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Cox Bryan F.'s filings is in WESTMINSTER, CO.

Recent filings by Cox Bryan F.

Oct 5, 2026: Open-market sale of TLSI shares (Form 4, code S).
Mar 16, 2026: Open-market sale of TLSI shares (Form 4, code S).
Mar 12, 2026: Open-market sale of TLSI shares (Form 4, code S).
Mar 11, 2026: Open-market sale of TLSI shares (Form 4, code S).
Nov 24, 2025: Grant or award of TLSI shares (Form 4, code A).

Other insiders filing for TriSalus Life Sciences, Inc. (TLSI)

Marshak Richard, Chief Commercial Officer
Stevens Jennifer, Chief Regulatory Officer
Szela Mary T, CEO and President
Patience David, Chief Financial Officer
Marshall Richard Henry, Chief Medical Officer
Wahlstrom Mats, Director

How to read Form 4 transaction codes